Modify the dosage to obtain an acceptable harmony concerning management of soreness and opioid-connected adverse reactions.If concomitant use of a CYP3A4 inhibitor is critical or if a CYP3A4 inducer is discontinued, take into account dosage reduction of acetaminophen and codeine phosphate tablets until eventually secure drug results are achieved.